ACell

ACell is a U.S.-origin medical brand focused on regenerative biologic materials, extracellular-matrix products, and tissue-repair applications. Its products were marketed in areas such as surgical care, wound management, and tissue reconstruction, with a core approach based on using biologic materials derived from animal tissues as scaffolds or coverings to support repair. Applications have included complex wounds, burns, surgical repair, and selected soft-tissue reconstruction procedures. In 2021, Integra LifeSciences announced the completion of its acquisition of ACell, after which ACell became part of Integra's business and product portfolio. Because the input does not include official source material or a complete independent-company history, this entry is limited to the brand positioning and acquisition relationship that can be stated with reasonable confidence.

ACell is a U.S. brand in regenerative medicine and tissue-repair materials, with a business centered on biologically derived extracellular-matrix materials and their medical applications. Its products were used in areas including wound care, burn treatment, surgical repair, and soft-tissue reconstruction, with product families such as MatriStem contributing to its market identity. In 2021, Integra LifeSciences completed its acquisition of ACell, after which ACell became part of Integra's brand and product assets. Reliable information is not available here to confirm ACell's exact founding year, founding team, former executives, or the extent of its independent brand operations after the acquisition, so those details are omitted.

• 2021

  Integra completes acquisition of ACell

  Integra LifeSciences completed the acquisition of ACell, incorporating ACell's regenerative medicine materials business and product portfolio into Integra.

Medical device and regenerative medicine materials brand, positioned in wound management, surgical repair, and tissue regeneration support.

• Biological regenerative materials

  MatriStem

  MatriStem was an ACell line of biologic regenerative materials based on extracellular-matrix technology, used in areas including wound care, surgical repair, and support for tissue regeneration.